Mazdutide Side Effects: Complete Profile, Management & When to Call Your Doctor

Introduction

Mazdutide’s side effect profile is dominated by gastrointestinal symptoms during the titration phase, with about 30% of GLORY-1 trial participants reporting nausea at the 6 mg dose. Most side effects are mild to moderate, peak during dose increases, and fade with continued use.

The drug activates both GLP-1 and glucagon receptors, which means it has a slightly different side effect signature than pure GLP-1 agents like semaglutide. The glucagon component adds a small heart rate bump and possibly more pronounced effects on lipid mobilization. The GLP-1 component drives the GI complaints that show up in every trial of every drug in this family.

This article walks through the full side effect profile based on GLORY-1, DREAMS-1, and DREAMS-2 trial data, covers practical management, and explains the warning signs that need a same-day call to your prescriber.

At TrimRx, we believe that understanding your options is the first step toward a more manageable health journey. You can take the free assessment quiz if you’re ready to see whether a personalized program is a fit for you.

What Are the Most Common Mazdutide Side Effects?

The most common side effects in clinical trials were nausea (30%), diarrhea (12%), vomiting (10%), constipation (8%), and reduced appetite (which is technically a desired effect). Side effect rates from GLORY-1 were similar to what STEP 1 reported for semaglutide and SURMOUNT-1 reported for tirzepatide.

Quick Answer: Nausea is the most common side effect, reported by 30% of patients on 6 mg in GLORY-1 (Ji et al. 2025 NEJM)

Most side effects appeared within the first 24 to 72 hours after an injection, especially during the first week of a new dose level. By the third or fourth dose at a given step, GI tolerance usually built up and symptoms eased. Patients who experienced the worst side effects at the 3 mg jump often did fine at 4.5 mg because tolerance had developed.

The frequency of side effects increased with dose. The 6 mg group had higher rates than the 4 mg group, which had higher rates than placebo. None of this is unique to mazdutide. It’s the standard GLP-1 family side effect pattern.

How Bad Is the Nausea Typically?

Most nausea on mazdutide is mild to moderate and resolves with practical adjustments to eating and hydration. Severe nausea requiring discontinuation occurred in roughly 3 to 5% of GLORY-1 participants, mostly during the early titration steps.

Mild nausea feels like queasiness, especially after eating. It often hits in the evening of injection day or the next morning. Moderate nausea adds occasional retching, reduced appetite to the point of skipping meals, and difficulty enjoying food. Severe nausea includes vomiting, inability to keep fluids down, and significant weight loss from inability to eat.

Practical tips that help: eat smaller meals, avoid fatty or fried foods for the first 48 hours after each shot, sip cold liquids slowly, try ginger tea or peppermint, and consider taking ondansetron (a prescription antiemetic) for the first week of a new dose. Some prescribers proactively prescribe ondansetron during titration.

What About Vomiting and Diarrhea?

About 10% of GLORY-1 participants reported vomiting at the 6 mg dose, and about 12% reported diarrhea. Both tend to occur in clusters around dose increases and fade with continued use.

Vomiting is more concerning than nausea because of dehydration and electrolyte risk. If you’re vomiting more than twice in 24 hours or can’t keep fluids down for a full day, that’s a call-your-prescriber moment. Most one-off vomiting episodes after a meal don’t need medical attention, but persistent vomiting does.

Diarrhea on mazdutide is usually loose stools rather than severe watery diarrhea. Adequate hydration handles most of it. Adding electrolyte supplements (potassium, magnesium, sodium) helps. If diarrhea persists more than three days or includes blood, get it evaluated.

Why Does Mazdutide Cause Constipation in Some People?

Mazdutide slows gastric emptying and gut motility throughout the digestive tract. For some patients this manifests as nausea; for others it shows up as constipation. About 8% of GLORY-1 participants reported constipation at the 6 mg dose.

Constipation on mazdutide responds well to standard interventions. Increasing water intake (two to three liters daily), adding 20 to 30 grams of fiber from vegetables, fruits, and whole grains, and walking regularly all help. Magnesium citrate at bedtime works well for many patients. Stool softeners like docusate are reasonable as a short-term measure.

If constipation lasts more than a week or causes abdominal pain and bloating, that’s worth a clinical evaluation. Rare but serious complications include small bowel obstruction, which has been reported in case studies for GLP-1 drugs but at very low rates.

Does Mazdutide Affect Heart Rate or Blood Pressure?

Resting heart rate rose 3 to 5 beats per minute on average at the maintenance dose in GLORY-1. Blood pressure dropped slightly, with systolic readings 6 to 7 mmHg lower at week 48 than baseline. Neither change required intervention in trials.

The heart rate increase is from the glucagon component, which has a mild stimulatory effect on the cardiovascular system. This is also seen with semaglutide and tirzepatide, where heart rate rises by similar magnitudes. There’s no signal of arrhythmia or increased cardiac events from this effect in clinical trials so far.

Blood pressure dropping is welcome news for most patients, since many people starting mazdutide have hypertension. The drop comes from weight loss, reduced sodium retention, and improved vascular function. Some patients with controlled hypertension end up needing lower doses of their BP medications after a few months on mazdutide.

What About Pancreatitis Risk?

Acute pancreatitis is a known but rare risk with all GLP-1 receptor agonists, including mazdutide. The signal in GLORY-1 was small (a few cases versus none in placebo) but consistent with the class.

Pancreatitis presents as severe upper abdominal pain, often radiating to the back, with nausea and vomiting. It’s not the routine nausea most patients get; it’s a different kind of pain. If you develop sudden severe abdominal pain that doesn’t get better within a few hours, stop the medication and go to an emergency room.

The absolute risk is low. Trial data across the GLP-1 class suggests roughly 1 to 3 cases per 1,000 patient-years. Patients with a history of pancreatitis or active gallstone disease are generally advised to use other treatments. The free assessment quiz at TrimRx screens for these conditions when matching patients to GLP-1 options.

Key Takeaway: Less than 5% of GLORY-1 participants discontinued for side effects

Does Mazdutide Cause Gallbladder Problems?

Rapid weight loss from any cause increases gallstone risk, and mazdutide is no exception. Trial reports show a small increase in gallbladder events (cholelithiasis, cholecystitis) versus placebo, similar to what semaglutide and tirzepatide show.

The mechanism is that rapid fat loss mobilizes cholesterol from fat stores into bile, which can form stones. Patients losing more than 1.5% of body weight per week have higher gallstone risk. Most stones are silent and never cause symptoms.

Warning signs of acute gallbladder problems include sharp pain in the upper right abdomen (especially after fatty meals), pain referred to the right shoulder, fever, jaundice (yellowing of skin or eyes), and dark urine. Any of these require prompt medical evaluation.

Are There Thyroid Concerns with Mazdutide?

GLP-1 receptor agonists carry a boxed warning in the US (for semaglutide and tirzepatide) about medullary thyroid carcinoma based on rodent studies. Mazdutide hasn’t been approved by the FDA yet, but if it is, it would likely carry the same warning.

The rodent data showed C-cell tumors at high doses. Whether this translates to humans is unclear, and large-scale postmarketing surveillance of semaglutide and tirzepatide hasn’t shown a clear cancer signal. Still, the standard contraindication for the class is personal or family history of medullary thyroid carcinoma or MEN-2 syndrome.

Patients with these histories should not take mazdutide. Patients with routine thyroid issues like Hashimoto’s, Graves’ disease, or non-medullary thyroid cancers don’t have this contraindication.

Can Mazdutide Cause Hair Loss?

Hair shedding can occur with rapid weight loss from any cause. It’s called telogen effluvium and typically starts two to four months after the weight loss begins. It’s not a direct effect of mazdutide; it’s an effect of rapid weight loss.

The shedding is usually temporary. Hair grows back over six to twelve months once weight stabilizes. Maintaining good nutrition during weight loss helps. Adequate protein (1.2 to 1.6 grams per kilogram of body weight daily), iron, zinc, biotin, and vitamin D are all important.

If hair loss is severe or doesn’t resolve after weight stabilizes, that warrants a workup for other causes including iron deficiency, thyroid dysfunction, or low protein status. Most patients don’t experience clinically significant hair loss on mazdutide, but some do.

What Are Injection Site Reactions Like?

Most patients have no injection site reactions or only minor ones: a small red spot, mild itching, or a brief sting at the time of injection. About 4 to 5% of GLORY-1 patients reported reactions worth mentioning.

Reactions usually fade within 24 to 48 hours. Rotating injection sites week to week reduces irritation. If a site becomes warm, hard, or persistently red beyond a few days, that could indicate a more significant reaction worth checking out.

Severe injection site reactions, including hives, swelling, or breathing difficulty, are rare and could indicate an allergic reaction to the drug itself or an excipient. Stop the medication and seek emergency evaluation in that case.

When Should You Call Your Doctor or Go to the ER?

Same-day call to your prescriber: persistent vomiting for more than 24 hours, unable to keep fluids down, fever, severe diarrhea, jaundice, signs of dehydration. Most of these don’t mean stopping the drug permanently but they need clinical guidance.

Emergency room: severe abdominal pain that doesn’t ease within a few hours, signs of pancreatitis (severe upper belly pain radiating to back plus vomiting), signs of severe allergic reaction (hives, difficulty breathing, facial swelling), severe gallbladder pain with fever or jaundice, vision changes (could indicate diabetic retinopathy progression in patients with diabetes), chest pain, or symptoms of severe hypoglycemia in patients on insulin or sulfonylureas.

The vast majority of mazdutide side effects are mild and self-managed at home. The serious ones above are rare, but knowing the warning signs reduces the risk of a bad outcome.

Bottom line: Serious side effects (pancreatitis, gallbladder disease, severe dehydration) are rare but require immediate medical attention

FAQ

How Long Do Side Effects Last?

Most GI side effects last one to four weeks per dose step. They tend to be worst in the first 72 hours after each dose increase and fade as tolerance develops. At maintenance dose, most patients have minimal ongoing side effects.

Can You Take Anti-nausea Medication with Mazdutide?

Yes. Ondansetron is commonly prescribed for use during titration. Many clinicians offer it proactively. Over-the-counter options like ginger, peppermint, or Dramamine can help mild nausea.

Does Eating Before the Shot Reduce Side Effects?

No clear evidence either way. Some patients find injecting on an empty stomach causes less nausea; others prefer with food. Try both approaches and see what works for you.

What If You Can’t Tolerate Even the Lowest Dose?

A small percentage of patients can’t tolerate even 1.5 mg. Options include extending the lowest dose for longer than four weeks, adding antiemetic medication, or switching to a different GLP-1 agent with a different side effect profile.

Will Side Effects Come Back at Higher Doses?

Usually, yes. Each new dose step triggers a fresh wave of GI symptoms because levels rise above the previous steady state. The pattern repeats but usually gets shorter and milder with each step.

Does the Drug Cause Depression?

GLP-1 drugs as a class have been investigated for possible mood effects. Large reviews so far don’t show clear depression or suicidality risk. Some patients report mood changes (positive or negative) but causation is unclear.

Are Side Effects Worse with Mazdutide Than Semaglutide?

Trial-to-trial comparison is rough but rates look similar. About 30% nausea on mazdutide 6 mg in GLORY-1 versus 44% on semaglutide 2.4 mg in STEP 1. Lower rates on mazdutide may reflect different trial populations rather than a real difference.

Disclaimer: This content is for informational purposes only and does not constitute medical advice. It is not intended to diagnose, treat, cure, or prevent any disease or condition. Individual results may vary. Always consult a qualified healthcare professional before starting any weight loss program or medication.